Assessing real-world outcomes in metastatic colorectal cancer with KRASG12C mutation.

Journal of Clinical Oncology(2020)

引用 1|浏览38
暂无评分
摘要
e16072Background: The KRASG12C mutation is present in 3% of colorectal cancer and is of particular interest given the recent development of specific targeting drugs. Previous data suggest KRAS (all...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要